Defective Drug Design a Global Problem

divider

With all the problems Americans have with defective drug design, it is easy to lose track of the fact that this is actually a worldwide problem. Most pharmaceuticals designed in America are also sold globally, meaning millions of more consumers are suffering negative side effects than many Americans realize.

Seventy Scottish plaintiffs are currently suing Pfizer, asking four and a half million dollars due to side effects of the drug Celebrex. The patients were prescribed Celebrex for arthritis pain. The victims suffered strokes and heart attacks after they began taking the medication.

Celebrex has been linked to a variety of negative health outcomes, including:

  • Strokes and heart attacks, as have been suffered by the victims in Scotland
  • Blood clots
  • Difficulty swallowing
  • Death

The risk profile for Celebrex is extremely high, a fact not always divulged to patients. Pfizer has been accused of failing to properly educate doctors and patients about the dangers presented by taking this medication. The pharmaceutical companies have been following the same playbook in Europe that they have in America, releasing potentially dangerous drugs to the marketplace.

Pfizer touts that Celebrex is available in over 100 countries, meaning there are over 100 countries with potential victims of defective drug design. Profits are paramount at pharmaceutical companies, and expanding the number of potential patients expands their profit margins. It also means more and more people are hurt by a dangerous drug.

If you or someone you love suffered a negative side effect due to Celebrex, and you feel you were not sufficiently informed of the risks, please contact an attorney. An experienced lawyer can evaluate your case and help you determine how to proceed to help keep other people, in the United States and worldwide, from being placed at unnecessary risk.